Novartis AG (NVS)
NYSE: NVS · Real-Time Price · USD
103.75
+0.66 (0.64%)
Nov 21, 2024, 12:58 PM EST - Market open
Novartis AG Analyst Ratings
Total Analysts
6
Consensus Rating
Hold
Price Target
$121.25
Upside
+16.87%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Erste Group | Erste Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 19, 2024 |
BMO Capital | BMO Capital | Hold Maintains $118 → $120 | Hold | Maintains | $118 → $120 | +15.66% | Oct 30, 2024 |
B of A Securities | B of A Securities | Strong Buy → Hold Downgrades $135 → $130 | Strong Buy → Hold | Downgrades | $135 → $130 | +25.30% | Sep 11, 2024 |
Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $119 → $121 | Strong Buy → Hold | Downgrades | $119 → $121 | +16.63% | Sep 5, 2024 |
Jefferies | Jefferies | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 3, 2024 |
Jefferies | Jefferies | Strong Buy Maintains $121 → $123 | Strong Buy | Maintains | $121 → $123 | +18.07% | Jul 2, 2024 |
BMO Capital | BMO Capital | Hold Maintains $114 → $116 | Hold | Maintains | $114 → $116 | +11.81% | Apr 24, 2024 |
BMO Capital | BMO Capital | Hold Initiates $114 | Hold | Initiates | $114 | +9.88% | Feb 23, 2024 |
Morgan Stanley | Morgan Stanley | Hold Initiates $114 | Hold | Initiates | $114 | +9.88% | Jan 23, 2024 |
Morgan Stanley | Morgan Stanley | Sell → Hold Upgrades n/a | Sell → Hold | Upgrades | n/a | n/a | Sep 25, 2023 |
Wolfe Research | Wolfe Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | May 9, 2022 |
Exane BNP Paribas | Exane BNP Paribas | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Dec 6, 2021 |
Bryan Garnier | Bryan Garnier | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 3, 2021 |
Deutsche Bank | Deutsche Bank | Hold → Strong Sell Downgrades n/a | Hold → Strong Sell | Downgrades | n/a | n/a | Sep 20, 2021 |
Argus Research | Argus Research | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 10, 2021 |
Cowen & Co. | Cowen & Co. | Buy → Hold Downgrades $110 → $105 | Buy → Hold | Downgrades | $110 → $105 | +1.20% | Feb 1, 2021 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.